In summary, our study reveals for the first time the expression status and prognostic value of SH3TC2 in pan-cancer and demonstrates the critical role of SH3TC2 in maintaining the cell-cycle progress and growth of CRC. The gene discussed is SH3TC2; the disease is colorectal carcinoma.